Glioblastoma is an aggressive brain tumor that usually occurs in late adulthood. Just two years after diagnosis, only 13.6 percent of patients are still alive. Standard treatment consists of surgery, followed by radiation ...
Jul 1, 2019
0
4
Since 2018, the immunosuppressant drug fingolimod has also been approved for children and adolescents aged 10 years and older whose relapsing remitting multiple sclerosis (RRMS) is highly active or severe and rapidly evolving. ...
Jun 24, 2019
0
0
Renal cell carcinoma is one of the cancers for which the range of promising treatment options has become considerably wider in recent years. In several early benefit assessments since 2013, the German Institute for Quality ...
May 17, 2019
0
1
In blister packaging, a pharmacy (or a service provider commissioned by it) portions and packs the prescribed drugs of a patient according to weekdays and times of day, sorted into individual transparent packages (blisters). ...
May 17, 2019
0
1
Do adult men with non-metastatic castration-resistant prostate cancer who have a high risk of developing metastases benefit from treatment with apalutamide—or would they do better to simply continue their conventional androgen ...
May 7, 2019
0
0
In 2017, the German Institute for Quality and Efficiency in Health Care (IQWiG) already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor versus the appropriate comparator ...
Apr 17, 2019
0
2
Erenumab was the first drug of a new drug class for the prophylaxis of migraine to enter the German market in November 2018. In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Feb 7, 2019
0
1
Serological group B streptococci (GBS) are common bacteria, which usually remain unnoticed. This is also the case for the almost 20% of pregnant women with vaginal or anal colonization of GBS. The bacteria pose a risk for ...
Feb 5, 2019
0
0
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx ...
Jan 17, 2019
0
0
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with ...
Jan 8, 2019
0
4
